RecruitingNot ApplicableNCT07712887

Puff Topography and Sensory Effects Across IQOS Device Generations

Puff Topography and Sensory Effects Across IQOS Device Generations: A Randomized Crossover Study


Sponsor

American University of Beirut Medical Center

Enrollment

50 participants

Start Date

Jul 27, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn how people use two generations of IQOS heated tobacco devices and how each device affects their smoking behavior and sensory experience. The main questions it aims to answer are: * Do participants puff differently when using the newer IQOS Iluma i compared to the older IQOS 2.4? * Does the flavor of the tobacco stick (preferred flavor vs. standard tobacco flavor) affect puffing behavior or sensory experience? * What are the differences in throat hit, mouthfeel, and satisfaction between the two devices? Participants will: * Attend 2 laboratory visits at the American University of Beirut * Use both the IQOS Iluma i and IQOS 2.4 devices during each visit * Have their puffing behavior recorded automatically during device use * Provide a breath sample before and after each use session * Complete short questionnaires about how each device felt and their urge to smoke


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria6

  • Current IQOS user (at least 3 days per week in the past 30 days)
  • Age 18 to 65 years
  • Generally healthy
  • Willing to provide informed written consent
  • Willing to attend all laboratory visits
  • Willing to abstain from all nicotine and tobacco products for at least 12 hours before each visit

Exclusion Criteria8

  • Use of any tobacco products other than IQOS in the past 30 days
  • Chronic cardiovascular conditions, seizures, or abnormal blood pressure
  • Current psychiatric disorder requiring active treatment, including major depressive disorder
  • Regular use of prescription medications that may influence cardiovascular function, respiratory function, or nicotine metabolism (excluding vitamins or birth control)
  • Use of cocaine, opioids, benzodiazepines, or methamphetamines in the past month
  • Marijuana use on more than 15 days per month
  • Current pregnancy or breastfeeding
  • Plans to quit nicotine or tobacco products within the next 30 days

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEIQOS Iluma i with TEREA Tobacco Sticks

The IQOS Iluma i is an induction-heated tobacco device used with TEREA STICKS. Participants use the device ad libitum during two smoking bouts (preferred flavor and Amber flavor conditions) across two study visits. Puff topography is recorded continuously during use.

DEVICEIQOS 2.4 with HEETS Tobacco Sticks

The IQOS 2.4 is a ceramic blade-heated tobacco device used with HEETS tobacco sticks. Participants use the device ad libitum during two smoking bouts (preferred flavor and Amber flavor conditions) across two study visits. Puff topography is recorded continuously during use.


Locations(2)

Clinical Aerosol Technology Laboratory (CATLAB), American University of Beirut

Beirut, Beirut, Lebanon

Clinical Aerosol Technology Laboratory (CATLAB), American University of Beirut

Beirut, Lebanon

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07712887


Related Trials